Superoxide dismutase - Applications and relevance to human diseases

Medical Science Monitor

Volumn 8, Issue 9, 2002, Pages

  Noor, Rana ^a   Mittal, Sonali ^a   Iqbal, Jawaid ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Alzheimer's disease; Cu, Zn SOD; Familial amyotrophic lateral sclorosis (FALS); Oxidative damage; Parkinson's disease; Superoxide radical

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; HYDROGEN PEROXIDE; OXYGEN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CANCER; DENGUE; DOWN SYNDROME; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME MECHANISM; GENE MUTATION; METAL BINDING; MOTOR NEURON DISEASE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PARALYSIS; PARKINSON DISEASE; REVIEW; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; FREE RADICALS; HUMANS; OXIDATIVE STRESS; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 4243336240     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Fridovich I: Superoxide radical and superoxide dismutase. Ann Rev Biochem, 1995; 64: 97-112
2. McCord JM: Superoxide radical, controversies, contradictions and paradoxes. Proc Soc Exp Biol Med, 1995; 209: 112-117
3. Iqbal J, Clerch LB, Hass MA et al: Endotoxin increases lung Cu, Zn superoxide dismutase mRNA: O2 raises enzyme synthesis. Am J Physiol: Lung Cell Mol Biol, 1989; 257: 61-64
4. Hass MA, Iqbal J, Clerch LB et al: Rat lung Cu, Zn superoxide dismutase: isolation and sequence of full length cDNA and studies of enzyme induction. J Clin Invest, 1989; 83: 1241-1246
5. Fridovich I: Superoxide dismutase. Adv Enzymol Relat, Areas Mol Biol, 1986; 41: 35-47
6. Steinman H: Superoxide dismutase. Protein chemistry and structuree-function relationship. In: Oberley LW (ed): Superoxide dismutase, vol. 1: 11-69. CRC press Boca Raton Fl
7. Bennister JV, Bannister WH, Rotillo G: Aspects the structure, function and applications of superoxide dismutase. CRC Crit Rev Biochem, 1987; 22: 111-180
8. Youn HD, Kim EJ, Roe JH et al: A novel nickel-containing superoxide dismutase from Streptomyces spp. Biochem J, 1996; 318: 889-896
9. Kim EJ, Kim HP, Hah YC, Roe JH: Differential expression of superoxide dismutase containing Ni and Fe/Zn in Streptomyces coelicolor. Eur J Biochem, 1996; 241: 178-189
10. Youn HD, Youn H, Lee JW et al: Unique enzyme of superoxide dismutase in Streptomyces griseus. Arch Biochem Biophys, 1996; 334: 341-348
11. Brown DR, Besinger A: Prion protein expression and superoxide dismutase activity. Biochem J, 1998; 334: 423-429
12. Pan chenko LF, Lamchingiin T, Gurasimov AM et al: Activity of superoxide dismutase in the blood of children with iron deficiency anemia. Vopr Med Khim, 1979; 25: 181-185
13. Mavelli I, Ciriolo MR, Rousi L et al: Favism: a hemolytic disease associated with increased superoxide dismutase and decreased glutathione peroxidase activities in red blood cells. Eur J Biochem, 1984; 139: 13-18
14. Concetti A, Massei P, Rotilio G et al: Superoxide dismutase in red blood cells: method of assay and enzyme content in normal subjects and in patients with B-thalassemia J. Lab Clin Med, 1976; 87: 1057-1064
15. Mizuno Y: Superoxide dismutase activity in early stages of development in normal and dystrophic chickens. Life Sci. 1984; 34: 909-914
16. Ray G, Kumar V, Kapoor AV et al: Status of antioxidants and other biochemical abnormalities in children with dengue fever. J Trop Pediatr, 1999; 45: 4-7
17. Gonzales R, Auclair C, Voisin E et al: Superoxide dismutase, catalase and glutathione peroxidase in red blood cells from patients with malignant disease. Cancer Res, 1984; 44: 4137-4139
18. Stieber AA, Gonatas JO, Gonatas NK: Aggregation of Ubiquitin and a mutant ALS-linked SOD 1 protein correlate with disease progression and fragmentation of Golgi apparatus. J Neurol Sci, 2000; 173: 53-62
19. Prusiner SB: Molecular biology of prion diseases. Science, 1991; 252: 1515-1522
20. Hsiao K, Prusiner SB: Inherited human prion diseases. Neurology, 1990; 49: 1820-1827
21. Famulari AL, Marschoff ER, Llesuy SF et al: The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and possible assay to differentiate demented subjects and controls. J Neurol Sci, 1996; 141: 69-78
22. Serra JA, Famulari AL, Kohan S et al: Copper Zinc superoxide dismutase activity in red blood cells in probable Alzheimer's patients and their first degree relatives. J Neurol Sci, 1994; 122: 179-188
23. Rhodin J, Thomas T, Bryant M, Sutton ET: Animal model of Alzheimer-like vascular pathology and inflammatory reaction. Ann N Y Acad Sci, 2000; 903: 345-352
24. Zemlan FP, Thienhaus OJ, Bosmann HB: Superoxide dismutase activity in Alzheimer's disease: Possible mechanism for paired helical filament formation. Brain Res, 1989; 476: 160-162
25. Delacourte A, Defossez A, Caballos I et al: Preferential localization of copper zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer's disease. Neurosci Lett, 1988; 92: 247-253
26. Kruman H, Pedersen WA, Springer JE, Mattson MP: ALS-linked Cu/Zn mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol, 1999; 160: 28-39
27. Vukosavic S, Dubois DM, Romero N, Przedborski S: Bax and BCl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem, 1999; 73: 2460-2468
28. Ratovitski T, Corson LB, Strain J et al: Variation in the biochemical/biophysical properties of mutant superoxide dismutase enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum Mol Genet, 1999; 8: 1451-1460
29. Pedersen WA, Mattson MP: No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn superoxide dismutase mutant mice. Brain Res, 1999; 833: 117-120
30. Facchinett F, Sasaki M, Cutting FB et al: Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosciences, 1999; 90: 1483-1492
31. Kato S, Saito M, Hirano A, Ohama E: Recent advances in research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutation: neuronal Lewy body-like hyaline inclusions and astrocytic hyaline inclusions. Histol Histopathol, 1999; 14: 973-980
32. Gurney ME, Pu H, Chin AY et al: Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 1994; 264: 1772-1775
33. Gurney ME: Transgenic animal models of familial amyotrophic lateral sclerosis. J Neurol, 1997; 244: 515-520
34. Dalcanto MC, Gurney ME: A low expressor line of transgenic mice carrying a mutant human Cu, Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol, 1997; 93: 537-550
35. Reaume AG, Elliot JL, Hoffman EK et al: Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Natl Genet, 1996; 13: 43-47
36. Rabizadeh S, Gralla EB, Borchelt DR et al: Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA, 1995; 92: 3024-3028
37. Carri MT, Ferri A, Battisfoni A et al: Expression of Cu, Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett, 1997; 414: 365-368
38. Jaarsma D, Haasdijk ED, Grashorn JAC et al: Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacoulization, axonal degeneration and premature motoneuron death and accelerates motoncuron disease in mice expressing a Familial Amyotrophic Lateral Sclerosis mutant SOD1. Neurobiol Diseases, 2000; 7: 623-643
39. Marklund SL, Andersen PM, Forsgren L et al: Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients. Neurochem, 1997; 69: 675-681
40. Ogawa Y, Kosaka H, Nakanishi T et al: Stability of mutant superoxide dismutase-1 associated with familial amyotrophic lateral sclerosis determines the manner of copper release and induction of thioredoxin in erythrocytes. Biochem Biophys Res Commun, 1997; 241: 251-257
41. Ratoviski A, Leigh PN: Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: Correlation between genotypes and clinical features. Neural Neurosurg Psychol, 1996; 61: 565-572
42. Siddiqui T ALS: Molecular clues to the jigsaw puzzle of neuronal degeneration. Cold Spring Harbor Syrup. Quant Biol, 1996; 61: 699-708
43. Afrasyap L, Guvenen G, Turkmen S: Plasma and erythrocyte total antioxidant status in patients with benign and malignant breast disease. Cancer Biochem, Biophys, 1998; 16: 129-138
44. Kong Q, Lillchei KO: Antioxidant inhibitors for cancer therapy. Med Hypothesis, 1998; 51: 405-409
45. Facchinetti F, Dawson VL, Dawson TM: Free radicals as mediators of neuronal injury. Cell Mol Neurobiol, 1908; 18: 667-682
46. Ihara Y, Chuda M, Kuroda S, Hayabara T: Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: Relationship to clinical data. J Neurol Sci, 1999; 170: 90-95
47. Grasbon Frodl EM, Kosel S, Riess O et al: Analysis of mitochodrial targeting sequence and coding region polymorphisms of the manganese superoxide dismutase gene in German Parkinson disease patients. Biochem Biophys Res Commun, 1999; 255; 749-752
48. Carlsson A, Greengard P, Kandel E: Signal transduction in the nervous system. Nobel Prize in Physiology and Medicine, 2000
49. Delcourt C, Cristol JP, Leyer CL et al: Association and antioxidant enzymes with cataract and age-related muscular degeneration. Ophthalmology, 1999; 106: 215-222
50. Pitkanan S, Robinson BH: Mitochondrial Complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest, 1996; 98: 345-351
51. Klaeger C, desa L, Klaeger AJ et al: An elevated level of copper zinc superoxide dismutase fails to prevent oxygen-induced retinopathy in mice. Br J Ophthalmol, 1996; 80: 429-434
52. Fydryk J, Jacobson E, Kurzawska O et al: Antioxidant status of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol, 1998; 12: 751-754
53. Tazum A, Aydin A, Turan M: Erythrocyte antioxidant activity and trace element levels in Behcet's disease. Biol Trace Elem Res, 1998; 64: 169-174
54. Dubick MA, Kun CL, Disilvestro RA et al: Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc Soc Exp Biol Med, 1999; 220: 39-45
55. Wang XL, Adachi T, Sim AS, Wilcken DC: Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler Tromb. Vasc Biol, 1998; 18: 1915-1921
56. Druzhyna N, Nair RG, LeDoux SP, Wilson GL: Defective repair of oxidative damage in mitochondrial DNA in Down's Syndrome. Mutat Res, 1998; 409: 81-89
57. Casado A, dela Torri R, Lopez-Fernandiz E et al: Superoxide, dismutase and catalase levels in diseases of the aged. Gac Med Mix, 1998; 134: 539-544
58. Dominguez C, Ruiz E, Gussinya M, Carrascosa A: Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes care, 1998; 21: 1736-1742
59. Eklad A, Ben Meir, D Breiterman S et al: Superoxide dismutase (SOD) for mustard gas burns. Burns, 1998; 24: 114-119
60. Danel C, Erzurum SC, Prayssac P et al: Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNA protects against hyperoxia but not against ischemia reperfusion lung injury. Human Gene Ther, 1998; 9: 1487-1496
61. Delanian S, Baillet F, Huart J et al: Successful treatment of radiation-induced fibrosis using liposamal Cu/Zn superoxide dismutase: Clinical trials. Radiother, Oncol, 32: 12-20
62. Koksoy FN, Kose H, Soybir GR et al: The prophylactic effects of superoxide dismutase, catalase, desferrioxamine, verapamil and disulliram in experimental colitis. J R Coll Surg Edimb, 1997; 42: 27-30
63. Ma EP, Liu XZ, Liu MD et al: The effect of superoxide dismutase on the recovery of human bone marrow hemopoietic stem cells stored at 4°C. Cryobiology, 1998; 37: 372-375